Exciting news! Arboretum Ventures’ portfolio company, NxThera, was acquired by Boston Scientific in a $400 million deal for its treatment of benign prostatic hyperplasia (BPH). According to the 2017 MVCA Research Report, while Michigan venture funds are investing in a variety of sectors, the life science sector continues to be a focus of capital deployment with 42 percent […]